Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study

医学 肺活量测定 优势比 横断面研究 人口 肺功能测试 肺活量 支气管扩张剂 气道 环境卫生 内科学 哮喘 麻醉 肺功能 病理 扩散能力
作者
Dan Xiao,Zhengming Chen,Sinan Wu,Kewu Huang,Jianying Xu,Lan Yang,Yongjian Xu,Xiangyan Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Wan-zhen Yao,Tieying Sun,Guangliang Shan,Ting Yang,Yingxiang Lin,Jianguo Zhu,Ruiying Wang
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:8 (11): 1081-1093 被引量:145
标识
DOI:10.1016/s2213-2600(20)30155-7
摘要

Background Small airway dysfunction is a common but neglected respiratory abnormality. Little is known about its prevalence, risk factors, and prognostic factors in China or anywhere else in the world. We aimed to estimate the prevalence of small airway dysfunction using spirometry before and after bronchodilation, both overall and in specific population subgroups; assess its association with a range of lifestyle and environmental factors (particularly smoking); and estimate the burden of small airway dysfunction in China. Methods From June, 2012, to May, 2015, the nationally representative China Pulmonary Health study invited 57 779 adults to participate using a multistage stratified sampling method from ten provinces (or equivalent), and 50 479 patients with valid lung function testing results were included in the analysis. We diagnosed small airway dysfunction on the basis of at least two of the following three indicators of lung function being less than 65% of predicted: maximal mid-expiratory flow, forced expiratory flow (FEF) 50%, and FEF 75%. Small airway dysfunction was further categorised into pre-small airway dysfunction (defined as having normal FEV1 and FEV1/forced vital capacity [FVC] ratio before bronchodilator inhalation), and post-small airway dysfunction (defined as having normal FEV1 and FEV1/FVC ratio both before and after bronchodilator inhalation). Logistic regression yielded adjusted odds ratios (ORs) for small airway dysfunction associated with smoking and other lifestyle and environmental factors. We further estimated the total number of cases of small airway dysfunction in China by applying present study findings to national census data. Findings Overall the prevalence of small airway dysfunction was 43·5% (95% CI 40·7–46·3), pre-small airway dysfunction was 25·5% (23·6–27·5), and post-small airway dysfunction was 11·3% (10·3–12·5). After multifactor regression analysis, the risk of small airway dysfunction was significantly associated with age, gender, urbanisation, education level, cigarette smoking, passive smoking, biomass use, exposure to high particulate matter with a diameter less than 2·5 μm (PM2·5) concentrations, history of chronic cough during childhood, history of childhood pneumonia or bronchitis, parental history of respiratory diseases, and increase of body-mass index (BMI) by 5 kg/m2. The ORs for small airway dysfunction and pre-small airway dysfunction were similar, whereas larger effect sizes were generally seen for post-small airway dysfunction than for either small airway dysfunction or pre-small airway dysfunction. For post-small airway dysfunction, cigarette smoking, exposure to PM2·5, and increase of BMI by 5 kg/m2 were significantly associated with increased risk, among preventable risk factors. There was also a dose-response association between cigarette smoking and post-small airway dysfunction among men, but not among women. We estimate that, in 2015, 426 (95% CI 411–468) million adults had small airway dysfunction, 253 (238–278) million had pre-small airway dysfunction, and 111 (104–126) million had post-small airway dysfunction in China. Interpretation In China, spirometry-defined small airway dysfunction is highly prevalent, with cigarette smoking being a major modifiable risk factor, along with PM2·5 exposure and increase of BMI by 5 kg/m2. Our findings emphasise the urgent need to develop and implement effective primary and secondary prevention strategies to reduce the burden of this condition in the general population. Funding Ministry of Science and Technology of China; National Natural Science Foundation of China; National Health Commission of China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lzx发布了新的文献求助10
2秒前
CipherSage应助muzi采纳,获得10
3秒前
4秒前
充电宝应助ChenChen采纳,获得10
4秒前
5秒前
5秒前
光储一体化完成签到,获得积分10
5秒前
风云鱼完成签到,获得积分20
6秒前
8秒前
景三发布了新的文献求助10
8秒前
9秒前
congenialboy发布了新的文献求助10
9秒前
乂贰ZERO叁发布了新的文献求助10
10秒前
拼搏梦旋发布了新的文献求助10
10秒前
12秒前
田様应助研究牛王采纳,获得10
12秒前
13秒前
冷漠的馄饨完成签到 ,获得积分10
17秒前
17秒前
小二郎应助漂亮元灵采纳,获得10
17秒前
ChenChen发布了新的文献求助10
18秒前
恋雅颖月应助congenialboy采纳,获得10
19秒前
ttttt完成签到,获得积分10
19秒前
开心岩发布了新的文献求助20
19秒前
诸葛天完成签到,获得积分10
19秒前
21秒前
辛夷发布了新的文献求助10
21秒前
超帅的碱应助lzx采纳,获得10
22秒前
AVEGETABLEBIRD关注了科研通微信公众号
23秒前
23秒前
Cheng完成签到 ,获得积分10
23秒前
脑洞疼应助李博士采纳,获得10
23秒前
Bio应助kingwill采纳,获得30
26秒前
超帅的访云完成签到,获得积分10
26秒前
强健的绮琴完成签到,获得积分10
26秒前
郝好完成签到 ,获得积分10
29秒前
香蕉觅云应助Accepted采纳,获得10
30秒前
斯文败类应助君知采纳,获得10
31秒前
科研通AI2S应助诸葛天采纳,获得10
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989645
求助须知:如何正确求助?哪些是违规求助? 3531805
关于积分的说明 11254983
捐赠科研通 3270372
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882136
科研通“疑难数据库(出版商)”最低求助积分说明 809176